Cargando…
The docking protein p130Cas regulates cell sensitivity to proteasome inhibition
BACKGROUND: The focal adhesion protein p130Cas (Cas) activates multiple intracellular signaling pathways upon integrin or growth factor receptor ligation. Full-length Cas frequently promotes cell survival and migration, while its C-terminal fragment (Cas-CT) produced upon intracellular proteolysis i...
Autores principales: | Zhao, Ming, Vuori, Kristiina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3215977/ https://www.ncbi.nlm.nih.gov/pubmed/22034875 http://dx.doi.org/10.1186/1741-7007-9-73 |
Ejemplares similares
-
Proteasome inhibition, the pursuit of new cancer therapeutics, and the adaptor molecule p130Cas
por: Chauhan, Dharminder, et al.
Publicado: (2011) -
Targeting p130Cas- and microtubule-dependent MYC regulation sensitizes pancreatic cancer to ERK MAPK inhibition
por: Waters, Andrew M., et al.
Publicado: (2021) -
p130Cas scaffold protein regulates ErbB2 stability by altering breast cancer cell sensitivity to autophagy
por: Bisaro, Brigitte, et al.
Publicado: (2015) -
uPAR promotes formation of the p130Cas–Crk complex to activate Rac through DOCK180
por: Smith, Harvey W., et al.
Publicado: (2008) -
Puromycin aminonucleoside modulates p130Cas of podocytes
por: Ha, Tae-Sun, et al.
Publicado: (2012)